Common Contracts
4 similar Representative’s Warrant Agreement contracts by E I L Holdings LTD, Inspira Technologies OXY B.H.N. LTD, Polyrizon Ltd., Tiziana Life Sciences PLC
Form of Representative’s Warrant AgreementRepresentative’s Warrant Agreement • August 15th, 2024 • E I L Holdings LTD • Wholesale-electronic parts & equipment, nec
THIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, EF Hutton, division of Benchmark Investments, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [_]1, 202_ (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(f)(2)(G)(i), prior to at 5:00 p.m. (New York time) on the date (such date, the “Termination Date”) that is five (5) years following the effective date of the initial public offering (the “Offering”), but not thereafter, to subscribe for and purchase from E I L Holdings Limited, a Cayman Islands company (the “Company”), up to [_] Ordinary Shares, par value $0.0001 per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Representative’s Warrant AgreementRepresentative’s Warrant Agreement • October 7th, 2022 • Polyrizon Ltd. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE ORDINARY SHARES(the “Warrant”) certifies that, for value received, Aegis Capital Corp., or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ], 2022 (the “Initial Exercise Date”)3 and prior to [ ], 2027 at 5:00 p.m. (New York time) (the “Termination Date”)4 but not thereafter, to subscribe for and purchase from POLYRIZON LTD., an Israeli company (the “Company”), up to [ ]ordinary shares par value NIS 0.04 per share (the “Ordinary Shares”), of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Representative’s Warrant AgreementRepresentative’s Warrant Agreement • June 28th, 2021 • Inspira Technologies OXY B.H.N. LTD • Surgical & medical instruments & apparatus
THIS WARRANT TO PURCHASE ORDINARY SHARES(the “Warrant”) certifies that, for value received, [______], or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ] [ ], 20212 (the “Initial Exercise Date”) and prior to [ ] [ ], 20263 at 5:00 p.m. (New York time) (the “Termination Date”) but not thereafter, to subscribe for and purchase from INSPIRA TECHNOLOGIES OXY B.H.N. LTD., an Israeli company (the “Company”), up to [______]4 ordinary shares par value NIS 0.125 per share (the “Ordinary Shares”), of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT A Form of Representative’s Warrant AgreementRepresentative’s Warrant Agreement • July 17th, 2019 • Tiziana Life Sciences PLC • Pharmaceutical preparations
THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ____, 2020 [THE DATE THAT IS 180 DAYS FROM THE EFFECTIVE DATE OF THE OFFERING] (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(f)(2)(G)(i), prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Tiziana Life Sciences plc, a public limited company incorporated in England and Wales (the “Company”), up to ______ Ordinary Shares of nominal value of £0.03 each, of the Company (as subject to adjustment hereunder, the “Warrant Shares”), represented by _____ American Depositary Shares (“ADSs”) as subject to adjustment hereunder, and the
